Description

n-(4-[2-(3,4-Dihydro-1H-Isoquinolin-2-Yl)Ethyl]Phenyl)-2-Nitrobenzamide is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel therapeutic agents targeting central nervous system and cardiovascular pathways. It is primarily utilized by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers engaged in the production of active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates, particularly those with potential neurological or cardiovascular activity.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new chemical entities.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis and scale-up projects.
• Academic Research: Utilized in university and institutional labs for studying heterocyclic chemistry and developing new synthetic methodologies.
• Preclinical Development: Serves as a starting material for producing compounds required for pharmacological screening and toxicology studies.

Basic Information

Product Name	n-(4-[2-(3,4-Dihydro-1H-Isoquinolin-2-Yl)Ethyl]Phenyl)-2-Nitrobenzamide
CAS No.	1024592-39-9
Molecular Formula	C24H23N3O3
Molecular Weight	401.46 g/mol
Synonyms	2-Nitro-N-[4-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]benzamide; N-(4-(2-(3,4-Dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-2-nitrobenzamide; 1024592-39-9; UNII-8J8V7QZ7QN; 8J8V7QZ7QN; Benzamide, N-[4-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-2-nitro-; SCHEMBL23306227; DTXSID60636669
EINECS	Contact for details

Quality Control

Our n-(4-[2-(3,4-Dihydro-1H-Isoquinolin-2-Yl)Ethyl]Phenyl)-2-Nitrobenzamide is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) with detailed chromatographic data are provided with each shipment to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to prevent any potential moisture uptake.

Specification

Item	Specification
Appearance	Yellow to light brown crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.